Semax 10mg

Semax Peptide

Semax is a synthetic heptapeptide derived from the adrenocorticotropic hormone (ACTH) fragment ACTH(4–10), modified to enhance stability and biological activity. Originally developed through neuropeptide research, Semax was designed to retain the neurotrophic and neuromodulatory properties of the parent peptide without exhibiting the hormonal activity associated with ACTH. Due to its unique mechanism of action, Semax has become an important subject in neuroscience research investigating cognitive function, neuroprotection, and central nervous system signaling.

Unlike traditional nootropic compounds that primarily influence neurotransmitter release or receptor activity, Semax appears to exert broader effects by modulating the expression of neurotrophic factors, particularly brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), while also influencing dopaminergic, serotonergic, and glutamatergic pathways. These characteristics have made Semax a valuable research tool for studying learning, memory, neuronal plasticity, and recovery following neurological injury.

---

Overview

Semax continues to be extensively investigated for its potential effects on cognitive performance, neuroprotection, and neuronal adaptation. Research suggests that the peptide may influence multiple signaling pathways involved in synaptic plasticity, neuronal survival, and cellular resilience. Experimental studies have demonstrated that Semax may enhance the expression of neurotrophic proteins involved in neuronal growth and repair while modulating neurotransmitter systems associated with attention, motivation, and memory formation.

In addition to its cognitive effects, researchers have examined Semax for its potential role in protecting neural tissue during conditions involving ischemia, oxidative stress, and neuroinflammation. Laboratory and clinical investigations have explored its ability to reduce neuronal damage following cerebral ischemia and other neurological insults, making it an important compound in ongoing neuroprotective research. Scientists continue to investigate additional applications involving mood regulation, neurodegenerative disorders, and central nervous system recovery, although these areas remain under active investigation.

Chemical Makeup

• Molecular Formula: C37H51N9O10S
• Molecular Weight: 813.93 g/mol
• Other Known Titles: Semax, ACTH(4–7)-Pro-Gly-Pro, Met-Glu-His-Phe-Pro-Gly-Pro

---

Research Studies and Clinical Trials

Cognitive Function and Memory

Semax has been widely studied for its potential effects on learning, memory, and cognitive performance. Experimental research suggests that the peptide may enhance synaptic plasticity through increased expression of neurotrophic factors such as BDNF while modulating neurotransmitter systems involved in attention and information processing. Researchers continue to investigate its potential role in improving cognitive function under conditions of neurological stress and cognitive impairment.

Neuroprotection and Cerebral Ischemia

One of the most extensively investigated applications of Semax involves neuroprotection following ischemic brain injury. Preclinical and clinical research has examined its effects on reducing neuronal damage associated with cerebral ischemia and stroke. Studies suggest that Semax may modulate inflammatory signaling, reduce oxidative stress, and support neuronal survival following ischemic events, although the precise mechanisms continue to be investigated.

Neurotrophic Factor Expression

Research has demonstrated that Semax may increase the expression of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and other genes involved in neuronal growth and repair. These findings have made the peptide an important research compound for investigating neuroplasticity, neuronal regeneration, and adaptive responses within the central nervous system.

Neurotransmitter and Stress Response Research

Semax has also been studied for its effects on dopaminergic, serotonergic, and glutamatergic signaling pathways. Experimental models suggest that the peptide may influence stress adaptation, emotional regulation, and cognitive resilience through modulation of neurotransmitter activity and gene expression. Although these findings remain an active area of investigation, they continue to support further research into the broader neurological actions of Semax.

---

Disclaimer: Semax is an experimental compound. It is not approved by the FDA or other major health authorities for human use. This description is for informational purposes based on current research data and does not constitute medical advice. Semax is available for research and laboratory purposes only.